INCY 5 (Jakafi 5 mg)
Generic Name: ruxolitinib
Pill with imprint INCY 5 is White, Round and has been identified as Jakafi 5 mg. It is supplied by Incyte Corporation.
Jakafi is used in the treatment of myelofibrosis; polycythemia vera; myeloproliferative disorders and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for INCY 5
Jakafi
- Generic Name:
- ruxolitinib
- Imprint:
- INCY 5
- Strength:
- 5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Incyte Corporation
- Inactive Ingredients:
- microcrystalline cellulose
lactose monohydrate
silicon dioxide
hydroxypropyl cellulose
povidone
sodium starch glycolate type A potato
magnesium stearate
Note: Inactive ingredients may vary.
More about Jakafi (ruxolitinib)
- Jakafi Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 8 Reviews
- Drug class: multikinase inhibitors
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
